The Global Sustained Release Excipients Market is Predict to reach $1.9 Billion by 2028, at a CAGR of 8.4%
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Sustained Release Excipients Market Growth, Trends and Report Highlights
According to a new report, published by KBV research, The Global Sustained Release Excipients Market size is expected to reach $1.9 billion by 2028, rising at a market growth of 8.4% CAGR during the forecast period.
The Transdermal market is poised to grow at a CAGR of 8.9% during (2022 - 2028). This method of administration reduces the number of drawbacks related to the parenteral and oral routes of administration. Transdermal patches are a simple way to promote the prolonged delivery of medications via the skin's surface. It is frequently chosen because it eliminates problems with the gastrointestinal system brought on by food interactions and enzymatic breakdown.
The Polymers market is leading the Global Sustained Release Excipients Market by Product in 2021; thereby, achieving a market value of $833.5 million by 2028. The usage of polymers in sustained-release formulations has significantly increased. For usage as an excipient in dry medicinal formulations, polymers have the ideal characteristics. Long molecules called polymers can be divided into smaller molecules. In addition to being composed of monomers, polymers also typically have a linear structure.
The Transdermal Technology market is expected to witness highest CAGR of 9.5% during (2022 - 2028). In comparison to conventional drug administration methods, transdermal sustained release technology provides a number of benefits, including the ability to circumvent hepatic first-pass metabolism, greatly reduce pharmacological side effects, and significantly increase patient compliance.
The Europe market dominated the Global Sustained Release Excipients Market by Region in 2021; thereby, achieving a market value of $670.9 million by 2028. The Asia Pacific market would witness a CAGR of 9% during (2022 - 2028). Additionally, The North America market is anticipated to grow at a CAGR of 7.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/sustained-release-excipients-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.
Global Sustained Release Excipients Market Segmentation
By Route of Administration
- Oral
- Transdermal
- Vaginal
- Intravenous
- Ophthalmic
- Subcutaneous
- Intramuscular
- Others
By Product
- Polymers
- Minerals
- Sugars
- Gelatin & Chitosan
- Others
By Technology
- Targeted Delivery
- Implants
- Wurster Technique
- Transdermal
- Micro Encapsulation
- Coacervation & Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- BASF SE
- International Flavors & Fragrances, Inc.
- Ashland Global Holdings Inc.
- Evonik Industries AG
- Croda International Plc
- Gattefossé
- Merck Group
- Pfizer, Inc.
- Novartis AG
- AstraZeneca Plc
Related Reports:
North America Sustained Release Excipients Market Size, 2028
- October-2022
- 92 Pages
LAMEA Sustained Release Excipients Market Size to 2022-2028
- October-2022
- 105 Pages
Europe Sustained Release Excipients Market Size to 2022-2028
- October-2022
- 105 Pages
Asia Pacific Sustained Release Excipients Market Size, 2028
- October-2022
- 105 Pages